EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice

Lauren Fraser iD, Nagham Ailabouni, Lisa Kalisch Ellett, Jiun Ming Tan, Anthea Freeman, Susanna M Proudman, Emily Reeve, Michael D Wiese

British Journal of Clinical Pharmacology · 2025-12 · 91 (12) · 3330-3340

DOI: 10.1002/bcp.70280 ↗

Kurz gefasst

Scoping Review in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 21.09.2025. Verfasst von Lauren Fraser und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of South Australia, Adelaide, South Australia. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Adherence to disease‐modifying antirheumatic drugs (DMARDs) has been associated with improved treatment outcomes, but how adherence is reported ranges between studies. We therefore aimed to determine how nonadherence to DMARDs used to treat rheumatoid arthritis (RA) has been measured and to report the nonadherence rate with each measure identified. Additionally, we aimed to explore what factors are associated with nonadherence.

Methods

A scoping review was conducted in the following databases: Embase, Medline, Scopus and Cochrane, searching from 2000 up to 31 August 2022 using search terms related to ‘adherence’; ‘measures’; rheumatoid arthritis'; and ‘medication’. Descriptive analyses were used to analyse and interpret the data according to the stated aims. We included 172 manuscripts that met the inclusion criteria and the median number of participants for each study was 249 (interquartile range 120–767). Measures of adherence included dispensing data, tablet counts, self‐report and physician estimates, electronic monitors, questionnaires and blood assays.

Results

Nonadherence was most commonly reported as a proportion and ranged from 1.5 to 100% for any DMARDs as a class, 0 to 95% for conventional synthetic DMARDs and 3 to 95% for biologic DMARDs. Increased disease activity, younger age and comorbidities were found in several studies to be associated with nonadherence, while there were inconsistent findings for sex, education, disease duration and other patient characteristics.

Conclusion

Much variability exists in the reported prevalence of nonadherence in RA, in what measures are used to assess nonadherence, how nonadherence is reported and which patient characteristics are associated with nonadherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsHumansPrevalenceFemale

Stichwörter der Autor:innen

adherencequality use of medicinesrheumatoid arthritis

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • University of South Australia, Adelaide, South Australia.
  • University of Queensland, Brisbane, Queensland, Australia.
  • Royal Adelaide Hospital, Adelaide, South Australia.
  • Monash University, Melbourne, Victoria, Australia.

ORCID-Profile: Lauren Fraser

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Fraser, L., Ailabouni, N., Ellett, L. K., Tan, J. M., Freeman, A., Proudman, S. M., Reeve, E., & Wiese, M. D. (2025). A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice. British Journal of Clinical Pharmacology, 91(12), 3330-3340. https://doi.org/10.1002/bcp.70280

Vancouver

Fraser L, Ailabouni N, Ellett LK, Tan JM, Freeman A, Proudman SM, et al. A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice. British Journal of Clinical Pharmacology. 2025;91(12):3330-3340. doi:10.1002/bcp.70280

BibTeX
@article{Fraser2025,
  author = {Fraser, Lauren and Ailabouni, Nagham and Ellett, Lisa Kalisch and Tan, Jiun Ming and Freeman, Anthea and Proudman, Susanna M and Reeve, Emily and Wiese, Michael D},
  title = {A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {12},
  pages = {3330--3340},
  doi = {10.1002/bcp.70280}
}
Kostenlos starten →